Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7500 p536
3 May 2008

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

• Trimethoprim (2)
• Personalised service
• Shambolic procedures
• White Paper
• Workload
• Patents and generics
• Learning@lunch
• Minority languages
• Domain names
• Public relations (2)
• New professional body (2)
• The Society


Letters to the Editor

Shambolic procedures

Penalty for providing unpaid services

From Mr A. R. Korsner, MRPharmS

It was tragic to read of a pharmacist being struck off for the crime of providing, what are often, unpaid NHS services. (“Shambolic” procedures lead to striking-off, PJ 19 April 2008, p487). It never has been possible or made economic sense to provide a compliance aid service for free.

This is clearly not a service to offer lightly and not one to be underestimated. To allot the time and space required and take the associated risks requires that a, not unsubstantial, fee be attached to the service.

When I did costings on behalf of several local pharmaceutical committees in 2004 it became clear that only by receiving a fee of about £200 for assessment and set-up costs and £400 per patient per year would a professional service be viable.

It was difficult to convince pharmacists of the need to spend adequate time in setting up and keeping the paperwork up to date and the dangers of just muddling through.

On the basis that you get what you pay for (and I do not know whether this particular pharmacist was receiving a payment from his primary care trust, but I will wager it was not as calculated as above) I am deeply saddened for the pharmacist concerned, but not surprised.

I am fortunate to be in the position of offering this service to my elderly mother. By the time I have checked the prescriptions, popped the medicines out of the foils, filled up the Dosette box and checked each compartment for “jumpers” the best part of an hour has passed.

What kudos or appreciation does the profession gain from being seen to have been involved in such a case and how can it be expected to be taken seriously in this and other ways?

The latest professional innovations seem to be taking us towards being GPs’ assistants (second class) instead of professionals in our own right. In my thoughts this is because we are not funded properly (less than £1 professional fee for a prescription, with all its responsibilities) and thus corners are inevitably cut. Only if we receive viable calculated fees for services should they be done.

I realise this may be seen as a retrograde step, but anyone working at the coal face will know how official “extended services” have impacted on their income so what is the point? My experience is that the word “shambolic” best describes many service payments from PCTs, like minor ailments. Even if we get them we can rarely check them against our submissions and we just have to trust to luck. If we are underpaid, tough luck, but if we overclaim, we are in trouble.

As a profession we should stop the infighting and rivalry, stop offering incentives for professional activities (free collections and delivery) and we just might regain the professional pride we had 20 odd years ago.

Adrian Korsner
London

Send your letter to The Editor

Previous Topic (Personalised service)
Next Topic (White paper)

Back to Top


©The Pharmaceutical Journal